By Promit Mukherjee and David Ljunggren OTTAWA, Feb 21 (Reuters) – he Bank of Canada’s 2% inflation target should be maintained in a review set for 2026, Governor Tiff Macklem said on Friday, saying central bank needed to focus on risks such as the imposition of U.S. tariffs. The bank and the finance ministry jointly …
Bank of Canada head wants review to leave 2% inflation target unchanged Read More »
By David Shepardson and Aditya Soni WASHINGTON (Reuters) -Tesla on Friday said it was recalling 376,000 of its electric vehicles in the U.S., due to a failure of the power steering assist feature that could make the vehicles harder to steer, particularly at low speeds, raising the risk of a crash. Tesla shares fell 3% …
Tesla recalls 376,000 vehicles in US over power steering, shares drop Read More »
(Reuters) – Ford Motor is recalling 240,510 vehicles in the U.S. over potential seat belt issues, the National Highway Traffic Safety Administration said on Friday. The recall affects certain 2020-2021 Ford Explorer and Aviator vehicles where the seat belt buckle anchor bolts may be improperly secured. As a remedy, dealers will inspect the bolts and …
Ford to recall over 240,000 vehicles in US over potential seat belt issues Read More »
(Reuters) – Rivian said on Friday it is recalling 17,260 vehicles in the U.S. due to a headlight issue that could reduce visibility and increase the risk of a crash. The recall affects certain 2025 R1S SUV and R1T pickup truck vehicles, the company said in a report with the National Highway Traffic Safety Administration. …
Rivian to recall over 17,000 vehicles in US over headlight issue Read More »
By Gabriella Borter WASHINGTON (Reuters) – The U.S. Senate passed a Republican bill promoting President Donald Trump’s immigration, energy and defense policies in the early hours of Friday morning, despite Trump’s preference for a House of Representatives version of the bill that would include trillions of dollars in tax cuts. The Senate’s narrower resolution, which …
US Senate passes Republican border security bill without Trump tax cuts Read More »
(Reuters) – Jennifer Granholm, the former U.S. secretary of energy and a Democratic two-term governor of Michigan, has been appointed to the boards of Edison International and its subsidiary, Southern California Edison, effective April 1, the company announced on Thursday. Granholm brings extensive experience in energy policy, particularly in advancing clean energy initiatives and zero-carbon …
Former US energy secretary Granholm joins Edison International, Socal Edison boards Read More »
(Reuters) – A high-level Japanese group that includes a former prime minister has drawn up plans for Tesla to invest in Nissan after the collapse of its merger talks with Honda, the Financial Times said on Friday. A separate Nikkei newspaper report said Taiwan’s Foxconn has proposed forming a partnership with Honda with an ultimate …
Japan seeks Tesla investment in Nissan, Foxconn approaches Honda, reports say Read More »
By Manya Saini (Reuters) – Payments firm Block’s shares tumbled 16% in morning trading on Friday as a slowdown in spending growth fueled investor concerns, shifting the spotlight to its bet on buy-now, pay-later lending to drive profits in 2025. Consumer spending growth has remained muted as Americans grapple with trade policy uncertainty under the …
Block shares drop as spending slowdown puts BNPL expansion in focus Read More »
(This Feb. 20 story has been corrected to fix the brokerage name to Needham, not Wedbush, in paragraph 7) By Ananya Mariam Rajesh (Reuters) – Celsius Holdings said on Thursday it would buy health and wellness drinks brand Alani Nutrition in a $1.8 billion deal through a combination of cash and stock, boosting its portfolio …
Celsius to buy energy drink brand Alani Nutrition in $1.8 billion deal Read More »
By Sneha S K (Reuters) -Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital Partners at a discount, after a prolonged struggle to survive a cash crunch due to a difficult market environment for gene therapies. The company first raised going concern doubts three years ago …
Gene therapy maker bluebird to go private in discounted deal amid cash crunch Read More »
